• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用药产品剂量的变异性是否会改变氢化可的松的皮肤吸收?

Is the Skin Absorption of Hydrocortisone Modified by the Variability in Dosing Topical Products?

作者信息

Paterson Daniel A, Hallier Jacqueline, Jenkins Elizabeth, Cordery Sarah F, Delgado-Charro M Begoña

机构信息

Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK.

出版信息

Pharmaceutics. 2018 Jan 12;10(1):9. doi: 10.3390/pharmaceutics10010009.

DOI:10.3390/pharmaceutics10010009
PMID:29329196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5874822/
Abstract

Fingertip units have been proposed as a tool to standardize topical therapy with semisolid formulations. However, no studies to date have characterized the variability in dosing by patients using this concept and whether this variability ultimately affects the topical absorption of drugs. This work aimed to answer these two questions. A first study determined the dose measured, the area of spread and the area-normalized dose for a 1% hydrocortisone cream and ointment applied by members of the public using this dosing approach before and after brief counselling. Then, in vivo tape-stripping and in vitro permeation studies investigated whether the variability in the area-normalized dose altered the skin absorption of hydrocortisone. Participants applied greater doses and spread them over larger areas after a short counselling intervention leading to smaller area-normalized doses. In vivo hydrocortisone uptake by the stratum corneum was significantly greater for the higher normalized dose and the differences were further supported by the in vitro permeation studies. However, these differences were relatively small and not proportional to the increase in normalized dose. This work shows that, following brief advice, patients and carers can apply consistent and sufficient doses of corticosteroids whilst minimizing risks and variability in hydrocortisone absorption.

摘要

指尖单位已被提议作为一种标准化半固体制剂局部治疗的工具。然而,迄今为止尚无研究描述患者使用这一概念时剂量的变异性,以及这种变异性是否最终会影响药物的局部吸收。这项工作旨在回答这两个问题。第一项研究确定了公众使用这种给药方法在接受简短咨询前后,应用1%氢化可的松乳膏和软膏时测量的剂量、涂抹面积和面积标准化剂量。然后,体内胶带剥离和体外渗透研究调查了面积标准化剂量的变异性是否改变了氢化可的松的皮肤吸收。经过简短的咨询干预后,参与者使用了更大的剂量并将其涂抹在更大的面积上,导致面积标准化剂量更小。角质层对氢化可的松的体内摄取在较高标准化剂量时显著更高,体外渗透研究进一步支持了这些差异。然而,这些差异相对较小,且与标准化剂量的增加不成比例。这项工作表明,在接受简短建议后,患者和护理人员可以应用一致且足够剂量的皮质类固醇,同时将氢化可的松吸收的风险和变异性降至最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/d9c621c9526f/pharmaceutics-10-00009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/53df6e9fbc69/pharmaceutics-10-00009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/d4dc944f3374/pharmaceutics-10-00009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/16edf399da53/pharmaceutics-10-00009-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/d9c621c9526f/pharmaceutics-10-00009-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/53df6e9fbc69/pharmaceutics-10-00009-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/d4dc944f3374/pharmaceutics-10-00009-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/16edf399da53/pharmaceutics-10-00009-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/5874822/d9c621c9526f/pharmaceutics-10-00009-g004.jpg

相似文献

1
Is the Skin Absorption of Hydrocortisone Modified by the Variability in Dosing Topical Products?局部用药产品剂量的变异性是否会改变氢化可的松的皮肤吸收?
Pharmaceutics. 2018 Jan 12;10(1):9. doi: 10.3390/pharmaceutics10010009.
2
The influence of dilution of topical semisolid preparations on hydrocortisone permeation through excised human stratum corneum.局部半固体制剂稀释对氢化可的松透过离体人角质层渗透的影响。
Eur J Pharm Biopharm. 2002 Sep;54(2):143-50. doi: 10.1016/s0939-6411(02)00054-1.
3
Comparison of tape stripping with the human skin blanching assay for the bioequivalence assessment of topical clobetasol propionate formulations.比较胶带剥离法与人体皮肤发白试验在评估局部用丙酸氯倍他索制剂生物等效性中的应用。
J Pharm Pharm Sci. 2010;13(1):11-20. doi: 10.18433/j3c01r.
4
Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.利用皮肤中的药物含量和皮肤变白生物测定法测定市售制剂中丙酸倍他米松局部生物利用度的可行性。
Pharm Res. 1992 Jan;9(1):45-51. doi: 10.1023/a:1018975626210.
5
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.新型维甲酸4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸的代谢与处置研究。第5篇通讯:影响大鼠经皮吸收的因素。
Arzneimittelforschung. 1997 Mar;47(3):270-5.
6
Measurement of the stratum corneum drug reservoir to predict the therapeutic efficacy of topical iododeoxyuridine for herpes simplex virus infection.测量角质层药物储库以预测局部应用碘脱氧尿苷治疗单纯疱疹病毒感染的疗效。
J Invest Dermatol. 1987 Dec;89(6):598-602. doi: 10.1111/1523-1747.ep12461357.
7
Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.未稀释和稀释的倍他米松-17-戊酸酯半固体制剂通过离体人角质层和人工皮肤构建体的渗透对比研究。
Skin Pharmacol Physiol. 2009;22(3):142-50. doi: 10.1159/000203368. Epub 2009 Feb 21.
8
Usefulness of pressure-sensitive adhesives as a pretreatment material before application of topical drug formulations and a peeling tape for excess stratum corneum layers.在应用局部用药物制剂和用于去除多余角质层的剥离胶带之前,压敏粘合剂作为预处理材料的效用。
Chem Pharm Bull (Tokyo). 2014;62(6):559-67. doi: 10.1248/cpb.c14-00087.
9
In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream.盐酸特比萘芬乳膏经皮给药的体外-体内相关性研究。
Drug Dev Ind Pharm. 2013 Sep;39(9):1372-7. doi: 10.3109/03639045.2012.718786. Epub 2012 Oct 12.
10
Distribution of salicylic acid in human stratum corneum following topical application in vivo: a comparison of six different formulations.体内局部应用后水杨酸在人体角质层中的分布:六种不同制剂的比较
Int J Pharm. 1999 Oct 25;188(2):145-53. doi: 10.1016/s0378-5173(99)00217-3.

引用本文的文献

1
Discovery of novel inhibitor of 11 beta-hydroxysteroid dehydrogenase type 1 using structure-based screening approach for the treatment of type 2 diabetes.利用基于结构的筛选方法发现新型11β-羟基类固醇脱氢酶1型抑制剂用于治疗2型糖尿病
J Diabetes Metab Disord. 2023 Mar 6;22(1):657-672. doi: 10.1007/s40200-023-01191-8. eCollection 2023 Jun.
2
Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling.皮肤生物利用度评估:利用表皮角质层取样预测局部皮质类固醇的输入函数。
Drug Deliv Transl Res. 2022 Apr;12(4):851-861. doi: 10.1007/s13346-021-01064-8. Epub 2021 Oct 1.

本文引用的文献

1
Topical bioavailability of diclofenac from locally-acting, dermatological formulations.双氯芬酸在局部作用的皮肤科制剂中的局部生物利用度。
Int J Pharm. 2017 Aug 30;529(1-2):55-64. doi: 10.1016/j.ijpharm.2017.06.063. Epub 2017 Jun 19.
2
Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.基于药代动力学的局部皮肤药品生物等效性评价方法
Clin Pharmacokinet. 2015 Nov;54(11):1095-106. doi: 10.1007/s40262-015-0292-0.
3
Optimizing outcomes for paediatric atopic dermatitis.优化儿童特应性皮炎的治疗结局。
Br J Dermatol. 2014 Jul;170 Suppl 1:31-7. doi: 10.1111/bjd.12976. Epub 2014 May 9.
4
Assessment of the lateral diffusion and penetration of topically applied drugs in humans using a novel concentric tape stripping design.利用新型同心胶带剥离设计评估局部应用药物在人体中的侧向扩散和渗透。
Pharm Res. 2012 Aug;29(8):2035-46. doi: 10.1007/s11095-012-0731-7. Epub 2012 Mar 16.
5
Basic drug information given by physicians is deficient, and patients' knowledge low.
J Dermatolog Treat. 2009;20(4):190-3. doi: 10.1080/09546630802570818.
6
Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.利用皮肤药代动力学改进局部皮肤药物产品的生物等效性评估。
Pharm Res. 2009 Feb;26(2):316-28. doi: 10.1007/s11095-008-9742-9. Epub 2008 Oct 22.
7
Dermatopharmacokinetics of betamethasone 17-valerate: influence of formulation viscosity and skin surface cleaning procedure.倍他米松 17-戊酸酯的皮肤药代动力学:制剂粘度和皮肤表面清洁程序的影响。
Eur J Pharm Biopharm. 2009 Feb;71(2):362-6. doi: 10.1016/j.ejpb.2008.10.001. Epub 2008 Oct 10.
8
Psoriasis: improving adherence to topical therapy.银屑病:提高局部治疗的依从性。
J Am Acad Dermatol. 2008 Dec;59(6):1009-16. doi: 10.1016/j.jaad.2008.08.028. Epub 2008 Oct 2.
9
A prospective study of patient adherence to topical treatments: 95% of patients underdose.一项关于患者局部治疗依从性的前瞻性研究:95%的患者用药剂量不足。
J Am Acad Dermatol. 2008 Dec;59(6):975-80. doi: 10.1016/j.jaad.2008.07.039. Epub 2008 Sep 24.
10
Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.倍他米松 17-戊酸酯的药效学和皮肤药代动力学:局部生物利用度评估
Br J Dermatol. 2009 Mar;160(3):676-86. doi: 10.1111/j.1365-2133.2008.08757.x. Epub 2008 Sep 6.